Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Epidural compression in neuroblastoma: Diagnostic and therapeutic aspects.
De Bernardi B, Balwierz W, Bejent J, Cohn SL, Garrè ML, Iehara T, Plantaz D, Simon T, Angelini P, Cama A, London WB, Kramer K, Katzenstein HM, Tortori-Donati P, Rossi A, D'Angio GJ, Evans AE. De Bernardi B, et al. Among authors: katzenstein hm. Cancer Lett. 2005 Oct 18;228(1-2):283-99. doi: 10.1016/j.canlet.2005.01.053. Cancer Lett. 2005. PMID: 15975710 Review.
Advances in the diagnosis and treatment of neuroblastoma.
Weinstein JL, Katzenstein HM, Cohn SL. Weinstein JL, et al. Among authors: katzenstein hm. Oncologist. 2003;8(3):278-92. doi: 10.1634/theoncologist.8-3-278. Oncologist. 2003. PMID: 12773750 Free article. Review.
Angiogenesis in neuroblastoma.
Katzenstein HM, Cohn SL, Crawford S, Meitar D. Katzenstein HM, et al. J Clin Oncol. 2000 Jul;18(14):2789-91. doi: 10.1200/JCO.2000.18.14.2789. J Clin Oncol. 2000. PMID: 10894881 No abstract available.
Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group.
Katzenstein HM, Chang KW, Krailo M, Chen Z, Finegold MJ, Rowland J, Reynolds M, Pappo A, London WB, Malogolowkin M; Children's Oncology Group. Katzenstein HM, et al. Cancer. 2009 Dec 15;115(24):5828-35. doi: 10.1002/cncr.24667. Cancer. 2009. PMID: 19813275 Free PMC article. Clinical Trial.
Outcome after reduced chemotherapy for intermediate-risk neuroblastoma.
Baker DL, Schmidt ML, Cohn SL, Maris JM, London WB, Buxton A, Stram D, Castleberry RP, Shimada H, Sandler A, Shamberger RC, Look AT, Reynolds CP, Seeger RC, Matthay KK; Children’s Oncology Group. Baker DL, et al. N Engl J Med. 2010 Sep 30;363(14):1313-23. doi: 10.1056/NEJMoa1001527. N Engl J Med. 2010. PMID: 20879880 Free PMC article. Clinical Trial.
Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapy.
Marachelian A, Desai A, Balis F, Katzenstein H, Qayed M, Armstrong M, Neville KA, Cohn SL, Bush M, Gunawan R, Lim AP, Smith MA, Smith LM. Marachelian A, et al. Cancer Chemother Pharmacol. 2016 Feb;77(2):405-12. doi: 10.1007/s00280-015-2955-9. Epub 2016 Jan 20. Cancer Chemother Pharmacol. 2016. PMID: 26791869 Free PMC article. Clinical Trial.
Antiangiogenic therapy inhibits human neuroblastoma growth.
Katzenstein HM, Salwen HR, Nguyen NN, Meitar D, Cohn SL. Katzenstein HM, et al. Med Pediatr Oncol. 2001 Jan;36(1):190-3. doi: 10.1002/1096-911X(20010101)36:1<190::AID-MPO1045>3.0.CO;2-I. Med Pediatr Oncol. 2001. PMID: 11464880
100 results